Log in
NASDAQ:MCRB

Seres Therapeutics SEC Filings & 10K Form

$26.35
-1.26 (-4.56 %)
(As of 12/1/2020 12:00 AM ET)
Add
Compare
Today's Range
$26.00
Now: $26.35
$28.58
50-Day Range
$27.61
MA: $31.96
$37.73
52-Week Range
$2.52
Now: $26.35
$38.50
Volume1.68 million shs
Average Volume1.15 million shs
Market Capitalization$2.40 billion
P/E RatioN/A
Dividend YieldN/A
Beta4.6

SEC Filings

Seres Therapeutics (NASDAQ:MCRB) SEC Filings

DateFilerForm TypeView
11/25/2020
5:02 PM
Berenson Stephen (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2020
5:00 PM
AFEYAN NOUBAR (Reporting)
Flagship Pioneering Fund VI General Partner LLC (Reporting)
Flagship Pioneering Fund VI, L.P. (Reporting)
Flagship Pioneering Inc. (Reporting)
Flagship Ventures Fund IV General Partner LLC (Reporting)
Flagship Ventures Fund IV, L.P. (Reporting)
Flagship Ventures Fund IV-Rx, L.P. (Reporting)
Nutritional Health LTP Fund General Partner LLC (Reporting)
Nutritional Health LTP Fund, L.P. (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2020
3:30 PM
Flagship VentureLabs IV, LLC (Filed by)
Seres Therapeutics (Subject)
Form SC 13D/A
11/20/2020
6:30 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2020
8:53 AM
Seres Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/21/2020
4:02 PM
Ege David S. (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2020
4:00 PM
Ege David S. (Reporting)
Seres Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/09/2020
1:17 PM
ARK Investment Management LLC (Filed by)
Seres Therapeutics (Subject)
Form SC 13G/A
09/10/2020
9:03 AM
FMR LLC (Filed by)
Seres Therapeutics (Subject)
Form SC 13G/A
09/09/2020
5:03 AM
Seres Therapeutics (Subject)
Sumitomo Mitsui Trust Holdings, Inc. (Filed by)
Form SC 13G/A
09/08/2020
12:28 PM
Nikko Asset Management Americas, Inc. (Filed by)
Seres Therapeutics (Subject)
Form SC 13G/A
08/19/2020
4:17 PM
Nestle Health Science US Holdings, Inc. (Filed by)
Seres Therapeutics (Subject)
Form SC 13D/A
08/17/2020
3:21 PM
Seres Therapeutics (Subject)
Form FWP
08/14/2020
4:08 PM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2020
4:05 PM
Seres Therapeutics (Filer)
Form 424B5
08/14/2020
4:03 PM
Seres Therapeutics (Filer)
Form 424B5
08/13/2020
5:05 AM
Seres Therapeutics (Subject)
Form FWP
08/11/2020
4:30 PM
Seres Therapeutics (Filer)
Form 424B5
08/11/2020
4:11 PM
Seres Therapeutics (Filer)
Form S-3ASR
08/10/2020
6:31 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/28/2020
9:01 AM
Seres Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/01/2020
3:07 PM
Seres Therapeutics (Issuer)
Young Teresa L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2020
3:05 PM
Seres Therapeutics (Issuer)
Young Teresa L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/22/2020
3:18 PM
Biondi Paul (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2020
6:00 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/07/2020
3:18 PM
Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2020
3:16 PM
Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/23/2020
6:16 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2020
11:15 PM
Seres Therapeutics (Filer)
Form EFFECT
03/18/2020
3:43 PM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2020
3:39 PM
Seres Therapeutics (Filer)
Form 424B5
03/09/2020
3:18 PM
Seres Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/02/2020
6:13 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2020
4:24 PM
Nikko Asset Management Americas, Inc. (Filed by)
Seres Therapeutics (Subject)
Form SC 13G/A
02/12/2020
5:02 AM
Seres Therapeutics (Subject)
Sumitomo Mitsui Trust Holdings, Inc. (Filed by)
Form SC 13G/A
02/07/2020
7:45 AM
BlackRock Inc. (Filed by)
Seres Therapeutics (Subject)
Form SC 13G
01/28/2020
3:07 PM
Seres Therapeutics (Issuer)
Shaff Eric D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2020
3:06 PM
DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2020
3:05 PM
Henn Matthew R. (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2020
3:05 PM
Aunins John G. (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
6:00 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2019
7:40 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2019
7:38 AM
Seres Therapeutics (Filer)
Form 424B5
11/25/2019
3:32 PM
Chapman Marcus (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
11:11 AM
FMR LLC (Filed by)
Seres Therapeutics (Subject)
Form SC 13G/A
11/05/2019
1:12 PM
Seres Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2019
6:00 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2019
4:01 PM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2019
5:19 AM
Seres Therapeutics (Subject)
Sumitomo Mitsui Trust Holdings, Inc. (Filed by)
Form SC 13G
09/06/2019
1:17 PM
Nikko Asset Management Americas, Inc. (Filed by)
Seres Therapeutics (Subject)
Form SC 13G
08/06/2019
6:51 PM
Berenson Stephen (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2019
6:49 PM
Berenson Stephen (Reporting)
Seres Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/06/2019
10:18 AM
Seres Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
6:04 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2019
6:01 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2019
3:25 PM
Seres Therapeutics (Subject)
Form SC 13G/A
06/28/2019
3:30 PM
Flagship VentureLabs IV, LLC (Filed by)
Seres Therapeutics (Subject)
Form SC 13D
06/28/2019
3:30 PM
Flagship Pioneering Fund VI General Partner LLC (Reporting)
Flagship Pioneering Fund VI, L.P. (Reporting)
Flagship Pioneering Inc. (Reporting)
Nutritional Health LTP Fund General Partner LLC (Reporting)
Nutritional Health LTP Fund, L.P. (Reporting)
Seres Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/20/2019
3:17 PM
AFEYAN NOUBAR (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:19 PM
Kim Lorence H. (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:19 PM
Pomerantz Roger (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:16 PM
AFEYAN NOUBAR (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:06 PM
Seres Therapeutics (Filer)
Form 424B5
06/12/2019
4:13 PM
Seres Therapeutics (Filer)
Form 424B5
05/02/2019
8:52 AM
Seres Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2019
6:03 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
3:14 PM
Seres Therapeutics (Filer)
Form DEFA14A
04/30/2019
3:10 PM
Seres Therapeutics (Filer)
Form DEF 14A
04/24/2019
3:15 PM
Chapman Marcus (Reporting)
Seres Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/18/2019
3:05 PM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2019
2:42 PM
Seres Therapeutics (Filer)
Form CT ORDER
03/11/2019
9:02 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2019
12:11 PM
Seres Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/06/2019
10:19 AM
Seres Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2019
6:00 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2019
6:18 PM
Henn Matthew R. (Reporting)
Seres Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/29/2019
5:55 PM
HORGAN KEVIN (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
5:55 PM
DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
5:52 PM
Seres Therapeutics (Issuer)
Shaff Eric D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
5:51 PM
Aunins John G. (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
5:51 PM
COOK DAVID N (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2019
6:10 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2018
3:11 PM
Aunins John G. (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2018
7:50 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2018
3:27 PM
Aunins John G. (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2018
9:11 AM
Seres Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2018
6:05 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2018
3:13 PM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2018
4:58 PM
HORGAN KEVIN (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2018
4:57 PM
HORGAN KEVIN (Reporting)
Seres Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/22/2018
6:03 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2018
3:16 PM
Aunins John G. (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2018
8:22 PM
Aunins John G. (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2018
3:49 PM
Pomerantz Roger (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2018
4:08 PM
Pomerantz Roger (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2018
3:49 PM
Seres Therapeutics (Issuer)
Zausner Meryl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2018
3:43 PM
Seres Therapeutics (Issuer)
Zausner Meryl (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/04/2018
6:49 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2018
12:06 PM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2018
10:37 AM
Seres Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
This page was last updated on 12/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.